The Who, What and How of Sarcoma (PRO 02)
This activity is comprised of a panel of four academic radiation oncologists from geographically different institutions. The activity is divided into an overview of sarcoma, treatment management recommendations, and finally specific techniques based on a variety of clinical scenarios. Discussion includes updates in classification and the clinical implications for different subtypes. The activity reviews the integration of radiation both with surgery and systemic therapy in pre-op and post-op localized disease as well as in unresectable and metastatic setting. Technical pearls are offered that can be utilized in the clinic based on anatomic location. The activity concludes with a series of real-world cases where audience members are polled followed by a panel discussion.
This activity is designed to meet the interests of radiation oncologists and residents.
Upon completion of this live activity, participants should be able to do the following:
- Identify the different treatment strategies based on clinical presentation.
- Implement different treatment techniques based on clinical scenario.
Manpreet Bedi, MD, MS, is employed by Medical College of Wisconsin. Dr. Bedi receives honoraria from Varian and Accuray.
Andrew J. Bishop, MD, is employed by the University of Texas MD Anderson Cancer Center.
Anusha Kalbasi, MD, is employed by Stanford University. Dr. Kalbasi sits on the Advisory Board of Certis Oncology and T Cure Therapeutics. Dr. Kalbasi receives research funding from Highlight Therapeutics.
Shauna Rosalie Campbell, MD, DO, is employed by Taussig Cancer Center, Cleveland Clinic.
All relevant financial relationships have been mitigated.
The person(s) above served as the developer(s) of this activity. Additionally, the Annual Refresher Course Planning Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.